1. Home
  2. FLUX vs SNTI Comparison

FLUX vs SNTI Comparison

Compare FLUX & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FLUX

Flux Power Holdings Inc.

HOLD

Current Price

$0.63

Market Cap

14.1M

Sector

Miscellaneous

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$0.38

Market Cap

12.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLUX
SNTI
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.1M
12.1M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
FLUX
SNTI
Price
$0.63
$0.38
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
431.0K
201.2K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
5.00
77.31
EPS
N/A
N/A
Revenue
$9,317,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$23.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
126.25
N/A
52 Week Low
$0.47
$0.33
52 Week High
$7.55
$2.88

Technical Indicators

Market Signals
Indicator
FLUX
SNTI
Relative Strength Index (RSI) 48.25 38.97
Support Level $0.51 $0.33
Resistance Level $0.85 $0.40
Average True Range (ATR) 0.09 0.04
MACD 0.01 0.01
Stochastic Oscillator 33.28 37.59

Price Performance

Historical Comparison
FLUX
SNTI

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc. designs, develops, manufactures, and sells a portfolio of lithium-ion energy storage solutions for the electrification of a range of industrial and commercial sectors, which include material handling, airport ground support equipment (GSE), and stationary energy storage. It offers a high-power battery cell management system(BMS). The BMS serves as the brain of the energy storage solution, managing cell balancing, charging, discharging, monitoring, and communication between the pack and the forklift. The company's product portfolio includes Battery Technology and Energy Management solutions.

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Share on Social Networks: